Oxcarbazepine and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Oxcarbazepine (oxcarbazepine), especially for people who are female, 10-19 old, have been taking the drug for 1 - 2 years also take Zofran, and have Narcolepsy.

The phase IV clinical study analyzes which people have Otitis when taking Oxcarbazepine. It is created by eHealthMe based on reports of 14,992 people who have side effects when taking Oxcarbazepine from the FDA, and is updated regularly.

What is Oxcarbazepine?

Oxcarbazepine has active ingredients of oxcarbazepine. It is often used in epilepsy. eHealthMe is studying from 15,495 Oxcarbazepine users. Check the latest studies of Oxcarbazepine.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,410 drugs and 1,835 conditions by eHealthMe. Check the latest studies of Otitis.

On Aug, 01, 2026

14,992 people reported to have side effects when taking Oxcarbazepine.
Among them, 41 people (0.27%) have Otitis.

Among these 41 people:

How long have people been on Oxcarbazepine when they have Otitis? *

What is the gender of people who have Otitis when taking Oxcarbazepine? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Otitis when taking Oxcarbazepine? *

What are other drugs people take besides Oxcarbazepine? *

What are other side effects people have besides Otitis? *

Balance Disorder: 10 people, 24.39%
Urinary Tract Infection: 9 people, 21.95%
Oropharyngeal Pain: 8 people, 19.51%
Psychomotor Hyperactivity (feelings of extreme restlessness): 8 people, 19.51%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 19.51%
Disturbance In Attention: 8 people, 19.51%
Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 8 people, 19.51%
Speech Disorder Developmental: 8 people, 19.51%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 8 people, 19.51%
Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 8 people, 19.51%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 17.07%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 17.07%
Hyperemesis Gravidarum (a condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance): 6 people, 14.63%
Nausea (feeling of having an urge to vomit): 6 people, 14.63%
Hereditary Angioedema (recurrent episodes of severe swelling): 4 people, 9.76%
Immunodeficiency Common Variable: 4 people, 9.76%
Infection: 3 people, 7.32%
Hypersensitivity: 2 people, 4.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 4.88%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Oxcarbazepine and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxcarbazepine:

Oxcarbazepine (15,495 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Oxcarbazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,410 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,835 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Oxcarbazepine) and Oxcarbazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.